| Plasma protein (albumin) catabolism by the tumor itself—implications for tumor metabolism and the genesis of cachexia G Stehle, H Sinn, A Wunder, HH Schrenk, JCM Stewart, G Hartung, ... Critical reviews in oncology/hematology 26 (2), 77-100, 1997 | 372 | 1997 |
| Microrheology of Erythrocytes and Thrombocytes, Blood Viscosity and the Distribution of Blood Flow in the Microcirculation M Boutet, U Fuchs, P Gaehtgens, OH Gauer, F Hammersen, DL Heene, ... Mikrozirkulation/Microcirculation, 289-384, 1977 | 270 | 1977 |
| Pathophysiology, clinical manifestations and therapy of consumption-coagulopathy (“Verbrauchskoagulopathie”) HG Lasch, DL Heene, K Huth, W Sandritter The American Journal of Cardiology 20 (3), 381-391, 1967 | 224 | 1967 |
| Adsorption of fibrinogen derivatives on insolubilized fibrinogen and fibrinmonomer DL Heene, FR Matthias Thrombosis Research 2 (2), 137-154, 1973 | 203 | 1973 |
| Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients J Harenberg, P Roebruck, DL Heene Pathophysiology of Haemostasis and Thrombosis 26 (3), 127-139, 1996 | 192 | 1996 |
| The fibrin assay comparison trial (FACT) CE Dempfle, S Zips, H Ergül, DL Heene, FACT Study Group Thrombosis and haemostasis 85 (04), 671-678, 2001 | 190 | 2001 |
| Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor G Huhle, C Abletshauser, N Mayer, G Weidinger, J Harenberg, DL Heene Thrombosis research 95 (5), 229-234, 1999 | 174 | 1999 |
| The loading rate determines tumor targeting properties of methotrexate albumin conjugates in rats G Stehle, H Sinn, A Wunder, HH Schrenk, S Schütt, W Maier-Borst, ... Anti-cancer drugs 8 (7), 667-685, 1997 | 169 | 1997 |
| Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients J Harenberg, B Kallenbach, U Martin, CE Dempfle, R Zimmermann, ... Thrombosis research 59 (3), 639-650, 1990 | 134 | 1990 |
| Die Klinik der Verbrauchskoagulopathie HG Lasch, K Huth, DL Heene, G Müller-Berghaus, MH Hörder, H Janzarik, ... DMW-Deutsche Medizinische Wochenschrift 96 (17), 715-727, 1971 | 125 | 1971 |
| Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients G Hartung, G Stehle, H Sinn, A Wunder, HH Schrenk, S Heeger, ... Clinical cancer research 5 (4), 753-759, 1999 | 120 | 1999 |
| Therapeutic application of subcutaneous low-molecular-weight heparin in acute venous thrombosis J Harenberg, K Huck, H Bratsch, G Stehle, CE Dempfle, K Mall, M Blauth, ... Haemostasis 20 (Suppl 1), 205-219, 1990 | 111 | 1990 |
| Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin G Huhle, M Geberth, U Hoffmann, DL Heene, J Harenberg Gynecologic and obstetric investigation 49 (1), 67-69, 2000 | 101 | 2000 |
| Enhanced albumin uptake by rat tumors A Wunder, G Stehle, H Sinn, H Schrenk, D Hoff-Biederbeck, F Bader, ... International journal of oncology 11 (3), 497-507, 1997 | 95 | 1997 |
| Pharmacokinetics of methotrexate–albumin conjugates in tumor-bearing rats G Stehle, A Wunder, H Sinn, HH Schrenk, S Schiitt, E Frei, G Hartung, ... Anti-cancer drugs 8 (9), 835-844, 1997 | 92 | 1997 |
| Long-term anticoagulation of outpatients with adverse events to oral anticoagulants using low-molecular-weight heparin J Harenberg, G Huhle, L Piazolo, C Giese, DL Heene Seminars in thrombosis and hemostasis 23 (02), 167-172, 1997 | 75 | 1997 |
| Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate G Stehle, A Wunder, HH Schrenk, G Hartung, DL Heene, H Sinn Anti-Cancer Drugs 10 (8), 785, 1999 | 70 | 1999 |
| Impaired fibrinolytic capacity and tissue plasminogen activator release in patients with restenosis after percutaneous transluminal coronary angioplasty (PTCA) W Kirschstein, S Simianer, CE Dempfle, H Keller, B Stegaru, P Rentrop, ... Thrombosis and haemostasis 62 (06), 772-775, 1989 | 69 | 1989 |
| The fibrin assay comparison trial (FACT): correlation of soluble fibrin assays with D-dimer CE Dempfle, S Zips, H Ergül, DL Heene, FACT Study Group Thrombosis and haemostasis 86 (11), 1204-1209, 2001 | 66 | 2001 |
| Analysis of fibrin formation and proteolysis during intravenous administration of ancrod CE Dempfle, S Argiriou, K Kucher, H Muller-Peltzer, K Rübsamen, ... Blood, The Journal of the American Society of Hematology 96 (8), 2793-2802, 2000 | 63 | 2000 |
